AdvanDx

AdvanDx

Rapid diagnostics for critical infections. Improving antibiotic decisions and patient outcomes..
  • Edit
DateInvestorsAmountRound

$5.0m

Series B

$5.0m

Series B

$5.0m

Series B

$15.0m

Series C

$8.0m

Series C
N/A

$4.0m

Debt
N/A

$3.5m

Debt
N/A

$2.2m

Early VC

$12.0m

Early VC
N/A

$2.5m

Debt

N/A

Acquisition
Total Funding$52.2m

Recent News about AdvanDx

Edit